Top of this page
Skip navigation, go straight to the content
Newsroom
•
Press Releases
Search Press releases
![CIMZIA[®] is the First and Only Biologic Approved in Europe with the Option for a Reduced Maintenance Dose for Patients Across the Full Axial Spondyloarthritis Spectrum](/_up/ucb_com_presscenter/images/presscenter_teaser_17.jpg?300)
05 Aug 2020
CIMZIA[®] is the First and Only Biologic Approved in Europe …
Read more
30 Jul 2020
Acquisitions and disposals of own shares
Read more
30 Jul 2020
Transparency notification FMR LLC.
Read more
29 Jul 2020
UCB enters into collaboration with Roche to develop antibody treatment …
Read more
27 Jul 2020
UCB Half Year Report 2020: UCB’s resilient product portfolio …
Read more
24 Jul 2020
Disposals of own shares
Read more
Stay up-to-date on the latest news and information from UCB